BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang SW, Ali ND, Zhong L, Shi J. MicroRNAs as biomarkers for human glioblastoma: progress and potential. Acta Pharmacol Sin 2018;39:1405-13. [PMID: 29417946 DOI: 10.1038/aps.2017.173] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhou J, Liu R. Upregulation of miR-144-3p expression attenuates glioma cell viability and invasion by targeting BCL6. Exp Ther Med 2021;22:1157. [PMID: 34504602 DOI: 10.3892/etm.2021.10591] [Reference Citation Analysis]
2 Le Fèvre C, Constans JM, Chambrelant I, Antoni D, Bund C, Leroy-Freschini B, Schott R, Cebula H, Noël G. Pseudoprogression versus true progression in glioblastoma patients: A multiapproach literature review. Part 2 - Radiological features and metric markers. Crit Rev Oncol Hematol 2021;159:103230. [PMID: 33515701 DOI: 10.1016/j.critrevonc.2021.103230] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
3 Gatto L, Franceschi E, Di Nunno V, Tosoni A, Lodi R, Brandes AA. Liquid Biopsy in Glioblastoma Management: From Current Research to Future Perspectives. Oncologist 2021. [PMID: 34105205 DOI: 10.1002/onco.13858] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Lanzillotti C, De Mattei M, Mazziotta C, Taraballi F, Rotondo JC, Tognon M, Martini F. Long Non-coding RNAs and MicroRNAs Interplay in Osteogenic Differentiation of Mesenchymal Stem Cells. Front Cell Dev Biol 2021;9:646032. [PMID: 33898434 DOI: 10.3389/fcell.2021.646032] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 14.0] [Reference Citation Analysis]
5 Kim J, Park MW, Park YJ, Ahn JW, Sim JM, Kim S, Heo J, Jeong JH, Lee M, Lim J, Moon JS. miR-542-3p Contributes to the HK2-Mediated High Glycolytic Phenotype in Human Glioma Cells. Genes (Basel) 2021;12:633. [PMID: 33922649 DOI: 10.3390/genes12050633] [Reference Citation Analysis]
6 Basso J, Paggi MG, Fortuna A, Vitorino C, Vitorino R. Deciphering specific miRNAs in brain tumors: a 5-miRNA signature in glioblastoma. Mol Genet Genomics 2022. [PMID: 35175428 DOI: 10.1007/s00438-022-01866-6] [Reference Citation Analysis]
7 Stakaitis R, Pranckeviciene A, Steponaitis G, Tamasauskas A, Bunevicius A, Vaitkiene P. Unique Interplay Between Molecular miR-181b/d Biomarkers and Health Related Quality of Life Score in the Predictive Glioma Models. Int J Mol Sci 2020;21:E7450. [PMID: 33050332 DOI: 10.3390/ijms21207450] [Reference Citation Analysis]
8 Zhao X, Chen X, Wu X, Zhu L, Long J, Su L, Gu L. Machine Learning Analysis of MicroRNA Expression Data Reveals Novel Diagnostic Biomarker for Ischemic Stroke. J Stroke Cerebrovasc Dis 2021;30:105825. [PMID: 34022583 DOI: 10.1016/j.jstrokecerebrovasdis.2021.105825] [Reference Citation Analysis]
9 Valtorta S, Salvatore D, Rainone P, Belloli S, Bertoli G, Moresco RM. Molecular and Cellular Complexity of Glioma. Focus on Tumour Microenvironment and the Use of Molecular and Imaging Biomarkers to Overcome Treatment Resistance. Int J Mol Sci 2020;21:E5631. [PMID: 32781585 DOI: 10.3390/ijms21165631] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
10 Li P, Xu Z, Liu T, Liu Q, Zhou H, Meng S, Feng Z, Tang Y, Liu C, Feng J, Fu H, Liu Q, Wu M. Circular RNA Sequencing Reveals Serum Exosome Circular RNA Panel for High-Grade Astrocytoma Diagnosis. Clin Chem 2021:hvab254. [PMID: 34942001 DOI: 10.1093/clinchem/hvab254] [Reference Citation Analysis]
11 Zhou J, Du G, Fu H. miR‑296‑3p promotes the proliferation of glioblastoma cells by targeting ICAT. Mol Med Rep 2020;21:2151-61. [PMID: 32323769 DOI: 10.3892/mmr.2020.11011] [Reference Citation Analysis]
12 Sun J, Sun Z, Gareev I, Yan T, Chen X, Ahmad A, Zhang D, Zhao B, Beylerli O, Yang G, Zhao S. Exosomal miR-2276-5p in Plasma Is a Potential Diagnostic and Prognostic Biomarker in Glioma. Front Cell Dev Biol 2021;9:671202. [PMID: 34141710 DOI: 10.3389/fcell.2021.671202] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Dai X, Huang R, Hu S, Zhou Y, Sun X, Gui P, Yu Z, Zhou P. A novel miR-0308-3p revealed by miRNA-seq of HBV-positive hepatocellular carcinoma suppresses cell proliferation and promotes G1/S arrest by targeting double CDK6/Cyclin D1 genes. Cell Biosci 2020;10:24. [PMID: 32128112 DOI: 10.1186/s13578-020-00382-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
14 Sun P, Hamblin MH, Yin K. Non-coding RNAs in the regulation of blood–brain barrier functions in central nervous system disorders. Fluids Barriers CNS 2022;19. [DOI: 10.1186/s12987-022-00317-z] [Reference Citation Analysis]
15 Tanaka S, Ohgidani M, Hata N, Inamine S, Sagata N, Shirouzu N, Mukae N, Suzuki SO, Hamasaki H, Hatae R, Sangatsuda Y, Fujioka Y, Takigawa K, Funakoshi Y, Iwaki T, Hosoi M, Iihara K, Mizoguchi M, Kato TA. CD206 Expression in Induced Microglia-Like Cells From Peripheral Blood as a Surrogate Biomarker for the Specific Immune Microenvironment of Neurosurgical Diseases Including Glioma. Front Immunol 2021;12:670131. [PMID: 34267749 DOI: 10.3389/fimmu.2021.670131] [Reference Citation Analysis]
16 Akhtar S, Vranic S, Cyprian FS, Al Moustafa AE. Epstein-Barr Virus in Gliomas: Cause, Association, or Artifact? Front Oncol 2018;8:123. [PMID: 29732319 DOI: 10.3389/fonc.2018.00123] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
17 Junior LGD, Baroni M, Lira RCP, Teixeira S, Fedatto PF, Silveira VS, Suazo VK, Veronez LC, Panepucci RA, Antônio DSM, Yunes JA, Brandalise SR, Dos Santos Aguiar S, Neder L, de Oliveira RS, Machado HR, Carlotti CG Jr, Tone LG, Valera ET, Scrideli CA. High-throughput microRNA profile in adult and pediatric primary glioblastomas: the role of miR-10b-5p and miR-630 in the tumor aggressiveness. Mol Biol Rep 2020;47:6949-59. [PMID: 32888124 DOI: 10.1007/s11033-020-05754-3] [Reference Citation Analysis]
18 Pottoo FH, Javed MN, Rahman JU, Abu-Izneid T, Khan FA. Targeted delivery of miRNA based therapeuticals in the clinical management of Glioblastoma Multiforme. Semin Cancer Biol 2021;69:391-8. [PMID: 32302695 DOI: 10.1016/j.semcancer.2020.04.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
19 Yang H, Song Z, Wu X, Wu Y, Liu C. MicroRNA-652 suppresses malignant phenotypes in glioblastoma multiforme via FOXK1-mediated AKT/mTOR signaling pathway. Onco Targets Ther 2019;12:5563-75. [PMID: 31371994 DOI: 10.2147/OTT.S204715] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
20 Wang T, Mao P, Feng Y, Cui B, Zhang B, Chen C, Xu M, Gao K. Blocking hsa_circ_0006168 suppresses cell proliferation and motility of human glioblastoma cells by regulating hsa_circ_0006168/miR-628-5p/IGF1R ceRNA axis. Cell Cycle 2021;20:1181-94. [PMID: 34024251 DOI: 10.1080/15384101.2021.1930357] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Liu Y, Jiang K, Zhi T, Xu X. miR-720 is a key regulator of glioma migration and invasion by controlling TARSL2 expression. Hum Cell 2021;34:1504-16. [PMID: 34024034 DOI: 10.1007/s13577-021-00551-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Cheng L, Peng R, Guo P, Zhang H, Liu D, Liao X, Liu Y, Mo X, Liao Y. A HIF1A/miR-485-5p/SRPK1 axis modulates the aggressiveness of glioma cells upon hypoxia. Exp Cell Res 2021;402:112547. [PMID: 33722639 DOI: 10.1016/j.yexcr.2021.112547] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Swellam M, Ezz El Arab L, Al-Posttany AS, B Said S. Clinical impact of circulating oncogenic MiRNA-221 and MiRNA-222 in glioblastoma multiform. J Neurooncol 2019;144:545-51. [PMID: 31422498 DOI: 10.1007/s11060-019-03256-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
24 Monie DD, Bhandarkar AR, Parney IF, Correia C, Sarkaria JN, Vile RG, Li H. Synthetic and systems biology principles in the design of programmable oncolytic virus immunotherapies for glioblastoma. Neurosurg Focus 2021;50:E10. [PMID: 33524942 DOI: 10.3171/2020.12.FOCUS20855] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Delgado-Martín B, Medina MÁ. Advances in the Knowledge of the Molecular Biology of Glioblastoma and Its Impact in Patient Diagnosis, Stratification, and Treatment. Adv Sci (Weinh) 2020;7:1902971. [PMID: 32382477 DOI: 10.1002/advs.201902971] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
26 Hu P, Wang K, Zhou D, Wang L, Zhao M, Wang W, Zhang Y, Liu Y, Yu R, Zhou X. GOLPH3 Regulates Exosome miRNA Secretion in Glioma Cells. J Mol Neurosci 2020;70:1257-66. [PMID: 32227282 DOI: 10.1007/s12031-020-01535-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Supplitt S, Karpinski P, Sasiadek M, Laczmanska I. Current Achievements and Applications of Transcriptomics in Personalized Cancer Medicine. Int J Mol Sci 2021;22:1422. [PMID: 33572595 DOI: 10.3390/ijms22031422] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
28 Wu W, Klockow JL, Zhang M, Lafortune F, Chang E, Jin L, Wu Y, Daldrup-Link HE. Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance. Pharmacol Res 2021;171:105780. [PMID: 34302977 DOI: 10.1016/j.phrs.2021.105780] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Huda MN, Nafiujjaman M, Deaguero IG, Okonkwo J, Hill ML, Kim T, Nurunnabi M. Potential Use of Exosomes as Diagnostic Biomarkers and in Targeted Drug Delivery: Progress in Clinical and Preclinical Applications. ACS Biomater Sci Eng 2021;7:2106-49. [PMID: 33988964 DOI: 10.1021/acsbiomaterials.1c00217] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
30 Liu JY, Fu WQ, Zheng XJ, Li W, Ren LW, Wang JH, Yang C, Du GH. Avasimibe exerts anticancer effects on human glioblastoma cells via inducing cell apoptosis and cell cycle arrest. Acta Pharmacol Sin 2021;42:97-107. [PMID: 32451414 DOI: 10.1038/s41401-020-0404-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
31 Maggio I, Franceschi E, Gatto L, Tosoni A, Di Nunno V, Tonon C, Brandes AA. Radiomics, mirnomics, and radiomirRNomics in glioblastoma: defining tumor biology from shadow to light. Expert Rev Anticancer Ther 2021;21:1265-72. [PMID: 34433354 DOI: 10.1080/14737140.2021.1971518] [Reference Citation Analysis]
32 Iaquinta MR, Lanzillotti C, Mazziotta C, Bononi I, Frontini F, Mazzoni E, Oton-Gonzalez L, Rotondo JC, Torreggiani E, Tognon M, Martini F. The role of microRNAs in the osteogenic and chondrogenic differentiation of mesenchymal stem cells and bone pathologies. Theranostics 2021;11:6573-91. [PMID: 33995677 DOI: 10.7150/thno.55664] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
33 Vojdani S, Ghaderian SMH, Zali A, Rakhshan A, Oraee Yazdani S, Poursheikhani A, Bidari Zerehpoush F, Sharifi G. Altered expression of EGFR and miR-34a derived from serum and tumoral tissue was associated with glioblastoma multiform. Exp Mol Pathol 2021;121:104655. [PMID: 34062187 DOI: 10.1016/j.yexmp.2021.104655] [Reference Citation Analysis]
34 Li L, Liu X, Ma X, Deng X, Ji T, Hu P, Wan R, Qiu H, Cui D, Gao L. Identification of key candidate genes and pathways in glioblastoma by integrated bioinformatical analysis. Exp Ther Med 2019;18:3439-49. [PMID: 31602219 DOI: 10.3892/etm.2019.7975] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
35 Chi Y, Liang Z, Guo Y, Chen D, Lu L, Lin J, Qiu S, Wang X, Qiu E, Lin F, Chen J, Luo S, Zheng D, Xu X. WBSCR22 confers cell survival and predicts poor prognosis in glioma. Brain Res Bull 2020;161:1-12. [PMID: 32380188 DOI: 10.1016/j.brainresbull.2020.04.024] [Reference Citation Analysis]
36 Li H, Wang D, Yi B, Cai H, Xi Z, Lou X, Li Z. Comprehensive Analysis of CD163 as a Prognostic Biomarker and Associated with Immune Infiltration in Glioblastoma Multiforme. Biomed Res Int 2021;2021:8357585. [PMID: 34395626 DOI: 10.1155/2021/8357585] [Reference Citation Analysis]
37 Garcia CM, Toms SA. The Role of Circulating MicroRNA in Glioblastoma Liquid Biopsy. World Neurosurg 2020;138:425-35. [PMID: 32251831 DOI: 10.1016/j.wneu.2020.03.128] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]